Home RxNorm 1013867 alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia] Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1013867
RxNorm name alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia]
Display name alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia]
Full name alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia]
Term type SBD
Status DailyMed mapping
Updated 2026-06-04 23:39:06 Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125325 Glassia Alpha-1-Proteinase Inhibitor (Human) 351(a) Rx 2026-07-01
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 83473cbb-48e4-42a2-81b6-4c851423da7b Glassia 1 MG Injection [PSN] · alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia] [SBD] · Glassia 1 MG Injection [SY] 3 31 These highlights do not include all the information needed to use GLASSIA safely and effectively. See full prescribing information for GLASSIA. GLASSIA ® (Alpha 1 -Proteinase Inhibitor (Human)) Injection, For Intravenous Use Initial U.S. Approval: 2010 20251202